Respiratory Syncytial Virus (RSV) Infections drugs in development, 2023

GlobalData tracks 184 drugs in development for Respiratory Syncytial Virus (RSV) Infections by 144 companies/universities/institutes. The top development phase for Respiratory Syncytial Virus (RSV) Infections is preclinical, with 92 drugs in that stage.

Temporal morphogen-driven neural induction spurs growth of expanded brain organoids with enhanced neuroepithelium formation

Researchers examinea the effects of temporal morphogen gradient during neural induction on the formation of brain organoids.

December 4, 2023

Additional drugmakers flag risks of working with WuXi amid heightened US scrutiny

More drug companies are disclosing the potential for clinical trial delays and drug shortages if the US government blacklists a family of WuXi companies used

April 3, 2024

Driver’s license laws for undocumented immigrants linked to improved birth outcomes

In 2023, Rhode Island, Massachusetts and Minnesota joined a growing list of states that allow undocumented immigrants to obtain driver’s licenses if an applicant can

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.